Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
[Epidemiology of neuromyelitis optica].
Hypersensitivity Responses in the Central Nervous System.
Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
Association between retinal nerve fiber layer thickness and magnetic resonance imaging findings and intelligence in patients with multiple sclerosis.
Evaluation of an Expanded Disability Status Scale (EDSS) modeling strategy in multiple sclerosis.
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
Mosaic Subventricular Origins of Forebrain Oligodendrogenesis.
Time to target brain atrophy and neurodegeneration in multiple sclerosis.
Stress as provoking factor for the first and repeated multiple sclerosis seizures.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: A potential link.
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis.
Optical coherence tomography: clinical applications in medical practice.
Secondary B Cell Receptor Diversification Is Necessary for T Cell Mediated Neuro-Inflammation during Experimental Autoimmune Encephalomyelitis.
Pharmaceutical approval update.
The best clinical paper on multiple sclerosis in 2014.
Chronic inflammatory demyelinating polyneuropathy with membranous nephropathy.
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases.
TLR2 Stimulation Regulates the Balance between Regulatory T Cell and Th17 Function: A Novel Mechanism of Reduced Regulatory T Cell Function in Multiple Sclerosis.
Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis.
Pages
« first
‹ previous
…
632
633
634
635
636
637
638
639
640
…
next ›
last »